Crohn's Disease (CD) Clinical Trial
Official title:
A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Subjects With Crohn's Disease
This is a open-label extension (OLE) study designed to evaluate the long-term efficacy, safety, and tolerability of Upadacitinib (ABT-494).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04524611 -
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)
|
Phase 3 | |
| Completed |
NCT02778464 -
Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
|
||
| Terminated |
NCT02775656 -
UCB Cimzia Pregnancy Follow-up Study
|
||
| Completed |
NCT02108821 -
Fecal Microbiota Transplantation in Pediatric Patients
|
Phase 1 | |
| Completed |
NCT04089514 -
A Real-world Study of Imraldi® Use
|
||
| Completed |
NCT01364896 -
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
|
||
| Completed |
NCT04271748 -
The Impact of Time Restricted Feeding in Crohn's Disease
|
N/A | |
| Completed |
NCT03801928 -
Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease
|
||
| Recruiting |
NCT04779320 -
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
|
Phase 3 | |
| Completed |
NCT01877577 -
Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D
|
N/A |